Content about Medicine

October 27, 2010

GlaxoSmithKline Consumer Healthcare on Thursday commended the Food and Drug Administration for holding a scientific...

PARSIPPANY, N.J. GlaxoSmithKline Consumer Healthcare on Thursday commended the Food and Drug Administration for holding a scientific workshop this week that focused on the risks and benefits associated with the long-term use of nicotine-replacement therapy products.

 

October 27, 2010

Navarro Discount Pharmacies has launched the second year of its free Diabetes Club for customers...

October 27, 2010

Supervalu on Thursday announced the launch of a comprehensive, whole-store health-and-wellness program called “living healthy...

MINNEAPOLIS Supervalu on Thursday announced the launch of a comprehensive, whole-store health-and-wellness program called “living healthy with my diabetes.”

 

The program offers a variety of resources to make life easier for customers living with diabetes, including educational materials, health screening tests, group and individual diabetes education and training programs, medication management consultations, nutrition information, dietary tools, products and other services.

 

 

October 27, 2010

Sexual dysfunction often is conceived as a male phenomenon, but it frequently affects women as...

NEW YORK Sexual dysfunction often is conceived as a male phenomenon, but it frequently affects women as well, and for a wide variety of reasons.

 

October 27, 2010

As part of its "Ask Us" pharmacy campaign launched some months back, Target is showcasing...

NEW YORK As part of its "Ask Us" pharmacy campaign launched some months back, Target is showcasing its full array of digestive offerings heading into what is traditionally a heartburn-heavy holiday season.

October 26, 2010

Patients with diabetes may seek information from their physicians outside of scheduled office visits but...

October 26, 2010

British drug maker GlaxoSmithKline will pay nearly $1 billion to the U.S. government to settle...

LONDON British drug maker GlaxoSmithKline will pay nearly $1 billion to the U.S. government to settle allegations that it sold contaminated and ineffective products.

 

The company will plead guilty to criminal charges relating to drugs made at a manufacturing plant in Cidra, Puerto Rico, which it closed in 2009, and pay $750 million. In a whistleblower suit filed by a former employee, it was alleged that the company knowingly sold defective supplies of various drugs, including the baby ointment Bactroban (mupirocin) and the antidepressant Paxil (paroxetine).

October 26, 2010

The charitable arm of the National Association of Chain Drug Stores announced its $1 million...

ALEXANDRIA, Va. The charitable arm of the National Association of Chain Drug Stores announced its $1 million contribution to the National Consumers League's medication adherence awareness campaign.

 

October 26, 2010

Drug maker Pharmaxis got promising results from an investigative treatment for cystic fibrosis, the company...

BALTIMORE Drug maker Pharmaxis got promising results from an investigative treatment for cystic fibrosis, the company said.

 

Pharmaxis announced results of two six-month phase-3 trials of 643 patients receiving Bronchitol (mannitol), which the company presented last week at the North American Cystic Fibrosis Conference in Baltimore.

 

 

October 26, 2010

Supplementing with fish oils could help improve gum health, according to research published in the...

ST. LOUIS, Mo. Supplementing with fish oils could help improve gum health, according to research published in the November issue of the Journal of the American Dietetic Association. Researchers from Harvard Medical School and Harvard School of Public Health found that dietary intake of polyunsaturated fatty acids like fish oil, known to have anti-inflammatory properties, shows promise for the effective treatment and prevention of periodontitis, otherwise known as gum disease.

October 25, 2010

Actavis last week recalled 18 lots of its patches designed to treat persistent, moderate to...

MORRISTOWN, N.J. Actavis last week recalled 18 lots of its patches designed to treat persistent, moderate to severe chronic pain.

October 25, 2010

Cirrus Healthcare Products recently announced the launch of ClearEars, earplugs that contain a polymer to...

COLD SPRING HARBOR, N.Y. Cirrus Healthcare Products recently announced the launch of ClearEars, earplugs that contain a polymer to draw water from the ears after water activities. Consumers with glue ear, a condition in which thick, sticky fluid collects behind the eardrum, discovered that ClearEars helps to alleviate this condition, the company said.

 

October 25, 2010

Standard Homeopathic Co., which manufactures homeopathic products under the Hyland’s brand in mass retail, on...

LOS ANGELES Standard Homeopathic Co., which manufactures homeopathic products under the Hyland’s brand in mass retail, on Saturday recalled its Hyland’s teething tablets “in an abundance of caution due to an FDA investigation of its manufacturing facility,” the company stated.

October 25, 2010

Drug maker Keryx Biopharmaceuticals has finished enrolling participants for a late-stage clinical trial of a...

NEW YORK Drug maker Keryx Biopharmaceuticals has finished enrolling participants for a late-stage clinical trial of a drug for patients on kidney dialysis, Keryx said Tuesday.

 

The company is conducting a phase-3 trial of Zerenex (ferric citrate) in patients with end-stage kidney disease on dialysis who have excessive phosphorous levels, a condition known as hyperphosphatemia.

 

 

Keryx said it expects to complete the study and report top-line data by the end of the year.

 

October 25, 2010

L'Oreal Paris is looking to crack the genetic code to younger-acting skin with the January...

NEW YORK L'Oreal Paris is looking to crack the genetic code to younger-acting skin with the January 2011 launch of its new Youth Code skin care collection.

October 25, 2010

The Natural Products Association on Monday wrote a letter to the producers of a PBS...

October 25, 2010

An investigative vaccine made by Novartis appears to offer good protection against meningococcal disease in...

BASEL, Switzerland An investigative vaccine made by Novartis appears to offer good protection against meningococcal disease in infants, according to results of a late-stage clinical trial released Monday.

 

The Swiss drug maker said results of a phase-3 trial showed that Menveo (meningococcal group A, C, W135 and Y) induced immune responses in a high percentage of babies against four strains of the bacteria. Meningococcal disease occurs suddenly and can cause serious illness and often death during the first year of life.

 

 

October 25, 2010

Procter & Gamble on Tuesday announced the signing of two NFL offensive linemen — New...

CINCINNATI Procter & Gamble on Tuesday announced the signing of two NFL offensive linemen — New York Giants’ David Diehl and Minnesota Vikings’ Anthony Herrera — as spokesmen of the frequent-heartburn remedy Prilosec OTC. The two NFL players will be part of the Prilosec OTC Living Proof campaign to share their heartburn protection stories over the course of the 2010-2011 NFL season.

 

October 25, 2010

Opening another front in its long campaign to extend electronic prescribing and health information technology...

NEW ORLEANS Opening another front in its long campaign to extend electronic prescribing and health information technology throughout the United States, e-prescribing platform provider Surescripts said Monday that it will expand its nationwide e-prescribing network to accelerate the digital transformation of the nation’s healthcare system by enabling the electronic exchange of all types of clinical information.

October 25, 2010

The temporary discontinuation of sales of a drug used by cancer patients led to a...

LAKE FOREST, Ill. The temporary discontinuation of sales of a drug used by cancer patients led to a slight dip in sales for Hospira during third quarter 2010, but the company nonetheless had strong sales overall, according to an earnings report released Tuesday.

 

October 24, 2010

The Food and Drug Administration declined to approve a regulatory approval application from Arena Pharmaceuticals...

SAN DIEGO The Food and Drug Administration declined to approve a regulatory approval application from Arena Pharmaceuticals and Eisai for a drug to treat obesity, the two companies said Saturday.

 

The FDA issued a complete response letter for the drug lorcaserin, designed for weight management and weight loss in patients who are overweight or obese and have at least one co-morbid condition. The FDA issues a complete response letter when it finishes reviewing an approval application, but issues remain that preclude final approval.

 

October 24, 2010

With strong support from pharmacy leaders, Congress is moving to shut down prescription medication abuse...

With strong support from pharmacy leaders, Congress is moving to shut down prescription medication abuse and diversion with a multipronged legislative cudgel.

Prior to its October recess, the U.S. House of Representatives passed three industry-backed bills in September to help seal up the nation’s leaky prescription drug pipeline. The bills are expected to pass under “suspension of the rules,” which allows for expedited consideration of legislation.

October 24, 2010

Health care’s lumbering shift to electronic prescribing and health information technology has been a long...

October 24, 2010

There is a pair of significant reasons sales of external analgesics, including heat and ice...

October 24, 2010

More than a quarter trillion dollars in pharmaceutical sales happened through primary healthcare distributors in...